Raphael Esson

Mr. Raphael Esson

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Biologicals
Verified
Journal Article
Open access
EAEric Abachin
Eric Abachin
SCSamantha Convers
Samantha Convers
SFStephanie Falque
Stephanie Falque
RERaphael Esson
Raphael Esson
LMLaurent Mallet
Laurent Mallet
NNNolwenn Nougarede
Nolwenn Nougarede
Polymerase chain reaction (PCR) is an important molecular biology technique for in vitro amplification of nucleic acids. Reverse transcriptase quantitative PCR (RT-qPCR) and more recently reverse transcriptase digital droplet PCR (RT-ddPCR) have been developed for the quantification of nucleic acids. We developed an RT-ddPCR assay for the quantification of attenuated dengue virus serotype 2 nucleic acid and compared it with a routine RT-qPCR assay. While the routine RT-qPCR assay targets the NS5 gene, the E gene was selected for the optimization of the RT-ddPCR assay conditions. The specificity of the assay was demonstrated using the attenuated dengue virus serotype 2 alone and in the presence of the other three dengue serotypes. The results from both assays for 25 samples of the attenuated dengue virus serotype 2 were found to be comparable, with an R2 from the linear regression analysis of >0.98. A major advantage of the RT-ddPCR assay is that it allows quantification of nucleic acid, without the need of a standard curve. RT-ddPCR can be implemented for the absolute quantification of dengue vaccine virus nucleic acid during the vaccine manufacturing process.

1 September 2020 in Biologicals
Verified
Journal Article
Open access
MSMartha Erika Navarro Sanchez
Martha Erika Navarro Sanchez
NDNicolas Devard
Nicolas Devard
CHCamille Houy
Camille Houy
EAEric Abachin
Eric Abachin
SGSabine Godard
Sabine Godard
NNNolwenn Nougarede
Nolwenn Nougarede

23 August 2022 in Vaccine
Verified
Journal Article
Open access
RERaphael Esson
Raphael Esson
ESEmanuel Rodrigues De Sousa
Emanuel Rodrigues De Sousa
LBLoic Benair
Loic Benair
NDNicolas Devard
Nicolas Devard
DSDamien Soulet
Damien Soulet
MSMartha Erika Navarro Sanchez
Martha Erika Navarro Sanchez
We assessed the genetic and phenotypic characteristics of a yellow fever vaccine candidate, which was cloned from a YF-VAX substrain selected for growth in Vero cells (vYF-247), during the manufacturing process from the master seed lot (MSL) and working seed lot (WSL) through to the drug substance (DS) stage. There were nine minor nucleotide variants observed from the MSL to the DS stage, of which five led to amino acid changes. The variant positions were, however, not known risks for any virulence modification. vYF-247 exhibits a homogenous plaque size profile (as expected for a cloned vaccine candidate) composed of small plaques (<1 mm) that remained consistent throughout the manufacturing process. In addition, there was no change in the viral replication rate. Of note, the DS sequences across the two manufacturing campaigns (2018 and 2019) were very similar suggesting a high batch-to-batch consistency. All MSL, WSL and DS batches exhibited similar neurovirulence profiles in mice and had a more attenuated neurovirulence phenotype than the YF-VAX (egg-based vaccine) comparator. Overall, the neurovirulence phenotype of vYF-247 does not change from MSL, WSL to DS. These data collectively support the safety and genetic stability of vYF-247 during the production process.

1 January 2022 in Talanta
Verified
Journal Article
Closed access
AFAntoine Francotte
Antoine Francotte
RERaphael Esson
Raphael Esson
EAEric Abachin
Eric Abachin
MVMelissa Vanhamme
Melissa Vanhamme
ADAlexandre Dobly
Alexandre Dobly
CVCeline Vanhee
Celine Vanhee

5 May 2023 in Biologicals
Verified
Journal Article
Open access
RERaphael Esson
Raphael Esson
SFStéphanie Falque
Stéphanie Falque
EAEric Abachin
Eric Abachin
SGSteve George
Steve George
NNNolwenn Nougarede
Nolwenn Nougarede
To improve pertussis toxin (PT) yield in B. pertussis strains for vaccine production a genetically-engineered strain (gdPT 191-134 strain) with a second copy of the genetically detoxified PT (gdPT) locus was developed. The consistency of the production and genetic stability of the strain when used for vaccine production must be established. We developed two simplex ddPCR assays with PCR systems for ptxA, the target gene present in two copies, and pgm, the reference gene present as a single copy. The ddPCR assay had sufficient precision to discriminate the copy number of the PT locus accurately in two B. pertussis strains: one copy in the parent, non -genetically-engineered strain and two copies in the gdPT 191-134 strain. Using the ddPCR assays, we were able to show that the ratio of the ptxA to pgm genes decreased during serial culture passages, due to the loss of PT locus, which in turn, resulted in lower levels of PT production over time. We were then able to assess culture conditions that improved the stability of the double locus, as shown by non-significant reduction in gdPT toxin yield.

2 January 2022 in Toxins
Verified
Journal Article
Open access
PDF file
JPJeroen L. A. Pennings
Jeroen L. A. Pennings
EAEric Abachin
Eric Abachin
RERaphael Esson
Raphael Esson
HHHennie Hodemaekers
Hennie Hodemaekers
AFAntoine Francotte
Antoine Francotte
Rob VandebrielRob Vandebriel
Rob Vandebriel
Background: Ensuring consistency of tetanus neurotoxin (TeNT) production by Clostridium tetani could help to ensure consistent product quality in tetanus vaccine manufacturing, ultimately contributing to reduced animal testing. The aim of this study was to identify RNA signatures related to consistent TeNT production using standard and non-standard culture conditions. Methods: We applied RNA sequencing (RNA-Seq) to study C. tetani gene expression in small-scale batches under several culture conditions. Results: We identified 1381 time-dependent differentially expressed genes (DEGs) reflecting, among others, changes in growth rate and metabolism. Comparing non-standard versus standard culture conditions identified 82 condition-dependent DEGs, most of which were specific for one condition. The tetanus neurotoxin gene (tetX) was highly expressed but showed expression changes over time and between culture conditions. The tetX gene showed significant down-regulation at higher pH levels (pH 7.8), which was confirmed by the quantification data obtained with the recently validated targeted LC-MS/MS approach. Conclusions: Non-standard culture conditions lead to different gene expression responses. The tetX gene appears to be the best transcriptional biomarker for monitoring TeNT production as part of batch-to-batch consistency testing during tetanus vaccine manufacturing.